Erratum: Dual inhibition of canonical and noncanonical NF-kB pathways demonstrates significant antitumor activities in multiple myeloma (Clin Cancer Res (2019) 18(4669–81)Doi:10.1158/1078-0432.CCR-12-0779)

Claire Fabre, Naoya Mimura, Kathryn Bobb, Sun Young Kong, Gullu Gorgun, Diana Cirstea, Yiguo Hu, Jiro Minami, Hiroto Ohguchi, Jie Zhang, Jeffrey Meshulam, Ruben D. Carrasco, Yu Tzu Tai, Paul G. Richardson, Teru Hideshima, Kenneth C. Anderson

Research output: Contribution to journalComment/debate

Abstract

In the original version of this article (1), Fig. 4E was missing splice lines at p50 and p52, between TNFa and PBS-1086, and consequently the Nucleolin panel did not line up with the other two blots. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret these errors. Reference 1. Fabre C, Mimura N, Bobb K, Kong SY, Gorgun G, Cirstea D, et al. Dual inhibition of canonical and noncanonical NF-kB pathways demonstrates significant antitumor activities in multiple myeloma. Clin Cancer Res 2012;18:4669–81.

Original languageEnglish (US)
Number of pages1
JournalClinical Cancer Research
Volume25
Issue number9
DOIs
StatePublished - Sep 1 2012
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Erratum: Dual inhibition of canonical and noncanonical NF-kB pathways demonstrates significant antitumor activities in multiple myeloma (Clin Cancer Res (2019) 18(4669–81)Doi:10.1158/1078-0432.CCR-12-0779)'. Together they form a unique fingerprint.

  • Cite this

    Fabre, C., Mimura, N., Bobb, K., Kong, S. Y., Gorgun, G., Cirstea, D., Hu, Y., Minami, J., Ohguchi, H., Zhang, J., Meshulam, J., Carrasco, R. D., Tai, Y. T., Richardson, P. G., Hideshima, T., & Anderson, K. C. (2012). Erratum: Dual inhibition of canonical and noncanonical NF-kB pathways demonstrates significant antitumor activities in multiple myeloma (Clin Cancer Res (2019) 18(4669–81)Doi:10.1158/1078-0432.CCR-12-0779). Clinical Cancer Research, 25(9). https://doi.org/10.1158/1078-0432.CCR-19-0959